Poly(ADP-ribose) polymerase-1 down-regulates BRCA2 expression through the BRCA2 promoter

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• BRCA2 is a critical tumor suppressor involved in DNA repair and genomic stability.
• Previous studies identified activators and a repressor of BRCA2 promoter activity, along with an inhibitory 67-bp region.
• The precise mechanism by which this 67-bp region regulates BRCA2 expression remained unclear.

Purpose of the Study:

• To identify the protein that binds to the silencer-binding region within the 67-bp repression region of the BRCA2 promoter.
• To elucidate the role of this protein in regulating BRCA2 expression.

Main Methods:

• Affinity purification and mass spectrometry to identify the binding protein.
• Gel shift, antibody super-shift, and chromatin immunoprecipitation (ChIP) assays to confirm in vitro and in vivo binding.
• Use of Parp-1 inhibitors and siRNA to assess the effect on BRCA2 expression and histone acetylation.

Main Results:

• Poly-(ADP-ribose) polymerase-1 (Parp-1) was identified as the 120-kDa protein binding to the BRCA2 promoter's repression region.
• Parp-1 was confirmed to associate with the BRCA2 promoter both in vitro and in vivo.
• Inhibition of Parp-1 activity or gene expression led to increased endogenous BRCA2 levels.
• Parp-1 inhibition reduced histone H3 lysine 9 acetylation and blocked Parp-1 binding to the promoter.

Conclusions:

• Parp-1 acts as a repressor of BRCA2 expression.
• Parp-1 down-regulates BRCA2 by interacting with a specific repression region on its promoter.
• Targeting Parp-1 may represent a therapeutic strategy to enhance BRCA2 function in DNA repair and maintain genomic integrity.